Skip to main content
Yoshi Innovation Spolka Akcyjna logo

Yoshi Innovation Spolka Akcyjna — Investor Relations & Filings

Ticker · YOS ISIN · PLACREO00019 LEI · 25940008LUC0QZ57OK94 WAR Professional, scientific and technical activities
Open in API
Filings indexed 119 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country PL Poland
Listing WAR YOS

About Yoshi Innovation Spolka Akcyjna

http://www.yoshisa.pl

Yoshi Innovation S.A. is a technology company focused on developing and commercializing innovations, primarily in the medical and defense fields. The company supports emerging enterprises through a comprehensive incubation strategy that includes providing capital, legal and marketing consulting, and assistance in securing project funding. In parallel, Yoshi Innovation conducts its own research and development, creating proprietary products and solutions. Key projects include the Hyperbary medical device for treating hard-to-heal wounds, a line of Polymertech training phantoms for medical procedures, the Plasma Fission plasma scalpel for non-invasive surgery, and the Wound Scanning diagnostic system. The company also provides specialized intellectual property protection services through its team of patent attorneys.

Recent filings

Filing Released Lang Actions
Dokonanie odpisu aktualizującego wartość akcji CTE Group S.A. - Content (PL)
Regulatory Filings Classification · 65% confidence The document is a corporate announcement by the management board describing the adoption of an impairment write-off on an equity investment and its impact on the company’s financial statements. It is not a full financial report, not an earnings release, not a dividend notice, not a management change, and contains no transcripts or presentations. It is a regulatory announcement/disclosure falling under the general “Regulatory Filings” category (RNS).
2026-05-29 Polish
Zawarcie porozumienia z Agencją Rozwoju Przemysłu S.A. dotyczącego projektu ksenotransplantacji klinicznej - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a company announcement about entering into a preparatory cooperation agreement with another entity for a project related to clinical xenotransplantation. It details the scope of the agreement, responsibilities of each party, and the nature of the project as preparatory and analytical without financial commitment. There are no financial statements, no regulatory certifications, no voting results, no management or board changes, no earnings data, and no mention of report publication. The content is a general regulatory announcement about a business development and cooperation agreement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-07 Polish
Znacząca redukcja zadłużenia Emitenta poprzez efektywną monetyzację portfela własności intelektualnej - Content (PL)
Capital/Financing Update Classification · 87% confidence The document is an announcement by Yoshi Innovation S.A. regarding the execution of a patent lease agreement that effectively converts PLN 565,000 of debt into a 36-month lease, highlighting the benefits to cash flow, balance sheet structure, and asset protection. This is a capital structure transaction and financing update rather than a routine regulatory notice, earnings release, or management report. Therefore, it fits the Capital/Financing Update category.
2026-04-27 Polish
Powzięcie informacji o wyborze oferty konsorcjum z udziałem Emitenta jako najkorzystniejszej oraz zawarciu umowy - Content (PL)
Regulatory Filings Classification · 74% confidence The document is a Polish regulatory-style announcement by Yoshi Innovation S.A. reporting that its consortium bid was selected for a contract and that the contract has been signed. It provides operational details (tender award, contract terms, signing date) rather than financial results, capital structure changes, governance disclosures, or specific ESG or management materials. There is no evidence of it being an earnings release, annual report, or other specific report type. Therefore, it falls into the general “Regulatory Filings” category for miscellaneous corporate announcements.
2026-04-17 Polish
Zawarcie umowy wyłącznej dystrybucji na terytorium Królestwa Maroka - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from Yoshi Innovation S.A. regarding the signing of a distribution agreement for its products in Morocco. It explicitly mentions the disclosure of this information under Article 17 of the MAR (Market Abuse Regulation) as a confidential/inside information report. Since it is a general regulatory announcement regarding a business contract that does not fit into specific categories like M&A, dividends, or financial results, it falls under the RNS (Regulatory Filings) category.
2026-02-11 Polish
Dostawa trenażerów medycznych PhantomHIP 2.0 dla jednostki wojskowej - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement from Yoshi Innovation S.A. regarding the delivery of training equipment to a military unit. It explicitly references Article 17, paragraph 1 of the MAR (Market Abuse Regulation), which is the standard regulatory framework for disclosing inside information in the EU. Since it is a general regulatory announcement regarding business operations that does not fit into specific categories like financial reports, dividends, or M&A, it falls under the RNS (Regulatory Filings) category.
2025-12-31 Polish

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.